Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.

Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 1111, Suchdauer: 0.83s

12 3 4 5 6 7 8 9 10 11 weiter »

1
Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON)

von Wim A. Wuyts ; Luca Richeldi ; Shervin Assassi ; et al.

BMC Pulmonary Medicine, Vol 26, Iss 1, Pp 1-9 (2025)

Schlagworte: Idiopathic pulmonary fibrosis; Progressive pulmonary fibrosis; Open-label extension; Autoimmune disease interstitial lung disease; Nonspecific interstitial pneumonia; Diseases of the respiratory system; RC705-779
- View full text via DOI
Merkliste

2
Deep Learning Classification of Systemic Sclerosis Skin Using the MobileNetV2 Model

von Akay, M. ; Du, Y. ; Sershen, C.L. ; et al.

IEEE Open Journal of Engineering in Medicine and Biology IEEE Open J. Eng. Med. Biol. Engineering in Medicine and Biology, IEEE Open Journal of. 2:104-110 2021
- Zum Volltext in IEEE Xplore
Merkliste

3
ALK5 inhibitor impact on bleomycin-induced systemic sclerosis mouse model via multifunctional optical coherence tomography

von Pavel V. Nikitin ; Harshdeep S. Chawla ; Jessica Gutierrez ; et al.

APL Bioengineering, Vol 9, Iss 4, Pp - (2025)

Schlagworte: Biotechnology; TP248.13-248.65; Medical technology; R855-855.5
- View full text via DOI
Merkliste

4
Moderators of Loneliness Trajectories in People with Systemic Sclerosis During the COVID-19 Pandemic: A SPIN COVID-19 Cohort Longitudinal Study

von Rapoport, Chelsea S. ; Choi, Alyssa K. ; Kwakkenbos, Linda ; et al.

International Journal of Behavioral Medicine: Official Journal of the International Society of Behavioral Medicine. 31(3):352-362
- Zum Volltext (via ReDI)
Merkliste

5
POS0253 DIFFERENCES IN THE EFFECT OF C4A and C4B COPY NUMBERS ON SSc SEROLOGICAL AND CLINICAL SUBTYPES

von Martinez-Lopez, J ; Rangel-Peláez, C ; Rodriguez-Martin, I ; et al.
- View full text via BASE
Merkliste

6
Safety and tolerability of nerandomilast in patients with pulmonary fibrosis: pooled data from the FIBRONEER-IPF and FIBRONEER-ILD trials*

von Gläser, S ; Oldham, J M ; Assassi, S ; et al.

Pneumologie ; 66. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. ; volume 80 ; ISSN 1438-8790
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

7
Effekt of nerandomilast on clinical outcomes in patients with progressive pulmonary fibrosis (PPF): results from the final database lock of the FIBRONEER-ILD trial*

von Wijsenbeek, M S ; Assassi, S ; Azuma, A ; et al.

Pneumologie ; 66. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. ; volume 80 ; ISSN 1438-8790
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

8
Distinct effects of complement C4A and C4B copy numbers in systemic sclerosis serological and clinical subtypes

von Martínez-López, J. ; Rangel-Peláez, C. ; Rodriguez-Martin, I. ; et al.

Arthritis & Rheumatology
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

9
POS1329 DESIGN OF A PHASE III, RANDOMISED, PLACEBO-CONTROLLED TRIAL OF BI 1015550 IN PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE

von Maher, T. ; Assassi, S. ; Azuma, A. ; et al.
- View full text via BASE
Merkliste

10
Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD)

von Toby M Maher ; Michael Kreuter ; Vincent Cottin ; et al.

BMJ Open Respiratory Research, Vol 10, Iss 1 (2023)

Schlagworte: Medicine; Diseases of the respiratory system; RC705-779
- View full text via DOI
Merkliste

11
Evaluation of Measurement Properties and Differential Item Functioning in the English and French Versions of the University of California, Los Angeles, Loneliness Scale-6: A Scleroderma Patient-Centered Intervention Network (SPIN) Study

von S. Rapoport, C ; Choi, AK ; Kwakkenbos, L ; et al.

Arthritis Care and Research (2023) (In press).

Schlagworte: SPIN COVID-19 Patient Advisory Team; SPIN Investigators
- View full text via BASE
Merkliste

12
Nerandomilast in Patients with Progressive Pulmonary Fibrosis

von Maher T ; Assassi S ; Azuma A ; et al.

Schlagworte: Pulmonary fibrosi; randomized clinical trial; progressive pulmonary fibrosi; IPF
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

13
Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes

von Acosta-Herrera M. ; Kerick M. ; Lopez-Isac E. ; et al.

Schlagworte: autoantibodie; genetic; immune complex disease; polymorphism; systemic sclerosis
- View full text via BASE
Merkliste

14
A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc.

von Saketkoo LA ; Frech T ; Varjú C ; et al.
- View full text via BASE
Merkliste

15
Baseline characteristics of patients enrolled in FIBRONEER(TM)-IPF, a Phase III randomised placebo-controlled trial of the preferential PDE4B inhibitor BI 1015550 in patients with idiopathic pulmonary fibrosis

von Koschel, D ; Richeldi, L ; Assassi, S ; et al.

Pneumologie ; 65. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. ; volume 79 ; ISSN 1438-8790
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

16
POS0845 EFFECTS OF NINTEDANIB ON CIRCULATING BIOMARKERS IN PATIENTS WITH PROGRESSIVE FIBROSING AUTOIMMUNE DISEASE-RELATED INTERSTITIAL LUNG DISEASES

von Maher, T. ; Bonella, F. ; Assassi, S. ; et al.

Annals of the Rheumatic Diseases ; volume 82, page 722 ; ISSN 0003-4967
- View full text via BASE
Merkliste

17
Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes

von Hanson, A.L. ; Sahhar, J. ; Ngian, G.-S. ; et al.

http://dx.doi.org/10.3389/fgene.2022.913196.

Schlagworte: systemic sclerosis (scleroderma); HLA association and disease; human disease genetics; killer immunoglobulin like receptor (KIR); immunogenetics
- View full text via BASE
Merkliste

18
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

von Kerick, Martin ; Acosta-Herrera, Marialbert ; Simeón-Aznar, Carmen Pilar ; et al.

npj Genomic Medicine. 7(1)
- Zum Volltext in PubMed Central
Merkliste

19
Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program

von Kwakkenbos, Linda ; Østbø, Nora ; Carrier, Marie-Eve ; et al.

Pilot and Feasibility Studies. 8(1)
- Zum Volltext in PubMed Central
Merkliste

20
Randomized controlled trial of an internet-based self-guided hand exercise program to improve hand function in people with systemic sclerosis: the Scleroderma Patient-centered Intervention Network Hand Exercise Program (SPIN-HAND) trial

von Kwakkenbos, Linda ; Carrier, Marie-Eve ; Welling, Joep ; et al.

Trials. 23(1)
- Zum Volltext in PubMed Central
Merkliste

21
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

22
47XXY and 47XXX in Scleroderma and Myositis

von Scofield, RH ; Lewis, VM ; Cavitt, J ; et al.
- View full text via BASE
Merkliste

23
Caractéristiques initiales des patients inclus dans FIBRONEER™-IPF, essai de phase III randomisé, contrôlé vs placebo de l’inhibiteur préférentiel PDE4B, nerandomilast, chez des patients atteints d’une FPI

von Lleu, P.L. ; Cottin, V. ; Richeldi, L. ; et al.

In Revue des Maladies Respiratoires Actualités January 2025 17(1):295-297
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

24
The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trial

von Nordlund, Julia ; Henry, Richard S. ; Kwakkenbos, Linda ; et al.

Trials. 22(1)
- Zum Volltext in PubMed Central
Merkliste

25
Effect of nintedanib on progression of systemic sclerosis-associated interstitial lung disease over 100 weeks: data from a randomized controlled trial

von Assassi, S ; Distler, O ; Allanore, Y ; et al.

844 ; 837

Schlagworte: Science & Technology; Life Sciences & Biomedicine; Rheumatology; MORTALITY; EFFICACY; SAFETY; SENSCIS trial investigators
- View full text via BASE
Merkliste

12 3 4 5 6 7 8 9 10 11 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag